U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.5660_5662del (p.Ser1887del) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 26, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002347332.2

Allele description [Variation Report for NM_000335.5(SCN5A):c.5660_5662del (p.Ser1887del)]

NM_000335.5(SCN5A):c.5660_5662del (p.Ser1887del)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.5660_5662del (p.Ser1887del)
HGVS:
  • NC_000003.12:g.38550709_38550711del
  • NG_008934.1:g.103964_103966del
  • NM_000335.5:c.5660_5662delMANE SELECT
  • NM_001099404.2:c.5663_5665del
  • NM_001099405.2:c.5609_5611del
  • NM_001160160.2:c.5564_5566del
  • NM_001160161.2:c.5501_5503del
  • NM_001354701.2:c.5606_5608del
  • NM_198056.3:c.5663_5665del
  • NP_000326.2:p.Ser1887del
  • NP_000326.2:p.Ser1887del
  • NP_001092874.1:p.Ser1888del
  • NP_001092874.1:p.Ser1888del
  • NP_001092875.1:p.Ser1870del
  • NP_001153632.1:p.Ser1855del
  • NP_001153633.1:p.Ser1834del
  • NP_001341630.1:p.Ser1869del
  • NP_932173.1:p.Ser1888del
  • NP_932173.1:p.Ser1888del
  • LRG_289t1:c.5661_5663del
  • LRG_289t2:c.5658_5660del
  • LRG_289t3:c.5661_5663del
  • LRG_289:g.103964_103966del
  • LRG_289p1:p.Ser1888del
  • LRG_289p2:p.Ser1887del
  • LRG_289p3:p.Ser1888del
  • NC_000003.11:g.38592200_38592202del
  • NM_000335.4:c.5658_5660delCTC
  • NM_001099404.1:c.5661_5663delCTC
  • NM_198056.2:c.5661_5663delCTC
  • NM_198056.2:c.5663_5665delCCT
  • NR_176299.1:n.6407_6409delCTC
Protein change:
S1834del
Molecular consequence:
  • NM_000335.5:c.5660_5662del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001099404.2:c.5663_5665del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001099405.2:c.5609_5611del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001160160.2:c.5564_5566del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001160161.2:c.5501_5503del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001354701.2:c.5606_5608del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_198056.3:c.5663_5665del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002652387Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 26, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002652387.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.5663_5665delCCT variant (also known as p.S1888del), located in coding exon 27 of the SCN5A gene, results from an in-frame CCT deletion at nucleotide positions 5663 to 5665. This results in the in-frame deletion of a serine residue at codon 1888, located in the C-terminal, cytoplasmic region. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024